Steven Belle, Ph.D., M.Sc.Hyg.

Selected recent publications:

  • King WC, Li J, Leisear K, Mitchell JE, Belle SH. Determining activity monitor wear time: An influential decision rule. Journal of Physical Activity and Health [Internet]. 2011;8(4):566-80.
  • Ramcharran D, Wahed AS, Conjeevaram HS, Evans RW, Wang T, Belle SH, Yee LJ. Serum lipids and their associations with viral levels and liver disease severity in a treatment-naïve chronic hepatitis C type 1-infected cohort. J Viral Hepat [Internet]. 2011;18(4):e144-52.
  • Schulz R, Czaja SJ, McKay JR, Ory MG, Belle SH. Intervention taxonomy (ITAX): Describing essential features of interventions. Am J Health Behav [Internet]. 2010;34(6):811-21.
  • Smith MD, Patterson EJ, Wahed AS, Belle SH, Bessler M, Courcoulas AP, Flum D, Mitchell JE, Pomp A, Pories WJ, Wolfe B. Response to letter to the editor regarding: An inverse relationship between surgeon volume and adverse outcomes after RYGB in the longitudinal assessment of bariatric surgery (LABS) study. Surgery for Obesity and Related Diseases [Internet]. 2010;6(5):588-9.
  • Ramcharran D, Wahed AS, Conjeevaram HS, Evans RW, Wang T, Belle SH, Yee LJ. Associations between serum lipids and hepatitis C antiviral treatment efficacy. Hepatology [Internet]. 2010;52(3):854-63.
  • Schulz R, Zdaniuk B, Belle SH, Czaja SJ, Michael Arrighi H, Zbrozek AS. Baseline differences and trajectories of change for deceased, placed, and community residing alzheimer disease patients. Alzheimer Dis Assoc Disord [Internet]. 2010;24(2):143-50.
  • Hawke RL, Schrieber SJ, Soule TA, Wen Z, Smith PC, Reddy KR, Wahed AS, Belle SH, Afdhal NH, Navarro VJ, Berman J, Liu QY, Doo E, Fried MW, SyNCH Trial Group. Silymarin ascending multiple oral dosing phase I study in noncirrhotic patients with chronic hepatitis C. J Clin Pharmacol [Internet]. 2010;50(4):434-49.
  • Smith MD, Patterson E, Wahed AS, Belle SH, Bessler M, Courcoulas AP, Flum D, Halpin V, Mitchell JE, Pomp A, Pories WJ, Wolfe B. Relationship between surgeon volume and adverse outcomes after RYGB in longitudinal assessment of bariatric surgery (LABS) study. Surgery for Obesity and Related Diseases [Internet]. 2010;6(2):118-25.
  • Inabnet III WB, Belle SH, Bessler M, Courcoulas A, Dellinger P, Garcia L, Mitchell J, Oelschlager B, O'Rourke R, Pender J, Pomp A, Pories W, Ramanathan R, Wahed A, Wolfe B. Comparison of 30-day outcomes after non-LapBand primary and revisional bariatric surgical procedures from the longitudinal assessment of bariatric surgery study. Surgery for Obesity and Related Diseases [Internet]. 2010;6(1):22-30.
  • Evon DM, Ramcharran D, Belle SH, Terrault NA, Fontana RJ, Fried MW. Prospective analysis of depression during peginterferon and ribavirin therapy of chronic hepatitis C: Results of the virahep-C study. Am J Gastroenterol [Internet]. 2009;104(12):2949-58.
  • Hoofnagle JH, Wahed AS, Belle SH. Reply to antonucci et al. J Infect Dis [Internet]. 2009;200(9):1485.
  • Dove LM, Rosen RC, Ramcharran D, Wahed AS, Belle SH, Brown RS, Hoofnagle JH. Decline in male sexual desire, function, and satisfaction during and after antiviral therapy for chronic hepatitis C. Gastroenterology [Internet]. 2009;137(3):873,884.e1.
  • Flum DR, Belle SH, King WC, Wahed AS, Berk P, Chapman W, Pories W, Courcoulas A, McCloskey C, Mitchell J, Patterson E, Pomp A, Staten MA, Yanovski SZ, Thirlby R, Wolfe B. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med [Internet]. 2009;361(5):445-54.
  • Iuliano AD, Feingold E, Wahed AS, Kleiner DE, Belle SH, Conjeevaram HS, Zmuda J, Liang TJ, Yee LJ. Host genetics, steatosis and insulin resistance among african americans and caucasian americans with hepatitis C virus genotype-1 infection. Intervirology [Internet]. 2009;52(1):49-56.
  • Hoofnagle JH, Wahed AS, Brown Jr. RS, Howell CD, Belle SH. Early changes in hepatitis C virus (HCV) levels in response to peginterferon and ribavirin treatment in patients with chronic HCV genotype 1 infection. J Infect Dis [Internet]. 2009;199(8):1112-20.

CONTACT INFORMATION

Steven Belle, PhD, MScHyg
Phone: (412) 624-3758
Email: belle@edc.gsph.pitt.edu